These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25645552)

  • 21. Angiotensin II in septic shock.
    Corrêa TD; Takala J; Jakob SM
    Crit Care; 2015 Mar; 19(1):98. PubMed ID: 25886853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II].
    Desachy A; Normand S; François B; Cassat C; Gastinne H; Vignon P
    Presse Med; 2000 Apr; 29(13):696-8. PubMed ID: 10797820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II for the emergency physician.
    Wallis MC; Chow JH; Winters ME; McCurdy MT
    Emerg Med J; 2020 Nov; 37(11):717-721. PubMed ID: 32075849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II in Vasodilatory Shock.
    Wakefield BJ; Busse LW; Khanna AK
    Crit Care Clin; 2019 Apr; 35(2):229-245. PubMed ID: 30784606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
    Chow JH; Wallis M; Lankford AS; Chancer Z; Barth RN; Scalea JR; LaMattina JC; Mazzeffi MA; McCurdy MT
    Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):67-73. PubMed ID: 32787515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressor dosing in septic shock.
    Alaniz C; Pollard S
    Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
    [No Abstract]   [Full Text] [Related]  

  • 31. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
    Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management.
    Senatore F; Balakumar P; Jagadeesh G
    Pharmacol Res; 2021 Dec; 174():105916. PubMed ID: 34597810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock.
    Khalique SC; Ferguson N
    Cardiol Rev; 2019; 27(3):167-169. PubMed ID: 30601161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock.
    Bartel B
    S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC; Beer KA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.